Advances in Urology
Volume 2009 (2009), Article ID 181927, 6 pages
doi:10.1155/2009/181927
Review Article

Retroperitoneal Lymph Nodes in Transitional Cell Carcinoma of the Kidney and Ureter

Shilajit D. Kundu1 and Scott E. Eggener2

1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
2Section of Urology, The University of Chicago Medical Center, Chicago, IL 60637, USA

Received 10 July 2008; Accepted 3 November 2008

Academic Editor: Norm D. Smith

Copyright © 2009 Shilajit D. Kundu and Scott E. Eggener. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Facts & Figures 2007, American Cancer Society, Atlanta, Ga, USA, 2007.
  2. A. Jemal, T. Murray, E. Ward, et al., “Cancer statistics, 2005,” CA: A Cancer Journal for Clinicians, vol. 55, no. 1, pp. 10–30, 2005.
  3. R. P. Huben, A. M. Mounzer, and G. P. Murphy, “Tumor grade and stage as prognostic variables in upper tract urothelial tumors,” Cancer, vol. 62, no. 9, pp. 2016–2020, 1988. View at Publisher · View at Google Scholar
  4. H. W. Herr and S. M. Donat, “Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy,” The Journal of Urology, vol. 165, no. 1, pp. 62–64, 2001. View at Publisher · View at Google Scholar · View at PubMed
  5. S. P. Lerner, D. G. Skinner, G. Lieskovsky, et al., “The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results,” The Journal of Urology, vol. 149, no. 4, pp. 758–765, 1993.
  6. M. C. Hall, S. Womack, A. I. Sagalowsky, T. Carmody, M. D. Erickstad, and C. G. Roehrborn, “Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients,” Urology, vol. 52, no. 4, pp. 594–601, 1998. View at Publisher · View at Google Scholar
  7. G. Novara, V. De Marco, F. Gottardo, et al., “Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers,” Cancer, vol. 110, no. 8, pp. 1715–1722, 2007. View at Publisher · View at Google Scholar · View at PubMed
  8. H. G. van der Poel, N. Antonini, H. van Tinteren, and S. Horenblas, “Upper urinary tract cancer: location is correlated with prognosis,” European Urology, vol. 48, no. 3, pp. 438–444, 2005. View at Publisher · View at Google Scholar · View at PubMed
  9. M. A. Brausi, M. Gavioli, G. De Luca, et al., “Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival,” European Urology, vol. 52, no. 5, pp. 1414–1420, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. G. A. Brown, J. E. Busby, C. G. Wood, et al., “Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?,” BJU International, vol. 98, no. 6, pp. 1176–1180, 2006. View at Publisher · View at Google Scholar · View at PubMed
  11. B. Hong, S. Park, J. H. Hong, C.-S. Kim, J. Y. Ro, and H. Ahn, “Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract,” Urology, vol. 65, no. 4, pp. 692–696, 2005. View at Publisher · View at Google Scholar · View at PubMed
  12. K. Saito, S. Kawakami, Y. Fujii, M. Sakura, H. Masuda, and K. Kihara, “Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically,” The Journal of Urology, vol. 178, no. 6, pp. 2291–2296, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. M. K. Hanna, R. D. Jeffs, J. M. Sturgess, and M. Barkin, “Ureteral structure and ultrastructure. Part I. The normal human ureter,” The Journal of Urology, vol. 116, no. 6, pp. 718–724, 1976.
  14. T. Kondo, H. Nakazawa, F. Ito, Y. Hashimoto, H. Toma, and K. Tanabe, “Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract,” Urology, vol. 69, no. 2, pp. 265–269, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. F. P. Secin, T. M. Koppie, J. I. M. Salamanca, et al., “Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer,” International Journal of Urology, vol. 14, no. 1, pp. 26–32, 2007. View at Publisher · View at Google Scholar · View at PubMed
  16. M. Roscigno, C. Cozzarini, R. Bertini, et al., “Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract,” European Urology, vol. 53, no. 4, pp. 794–802, 2008. View at Publisher · View at Google Scholar · View at PubMed
  17. H. Miyake, I. Hara, K. Gohji, S. Arakawa, and S. Kamidono, “The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract,” British Journal of Urology, vol. 82, no. 4, pp. 494–498, 1998. View at Publisher · View at Google Scholar
  18. F. Rabbani, M. Perrotti, P. Russo, and H. W. Herr, “Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance,” Journal of Clinical Oncology, vol. 19, no. 1, pp. 94–100, 2001.
  19. S. Johansson and L. Wahlqvist, “A prognostic study of urothelial renal pelvic tumors: comparison between the prognosis of patients treated with intrafascial nephrectomy and perifascial nephroureterectomy,” Cancer, vol. 43, no. 6, pp. 2525–2531, 1979. View at Publisher · View at Google Scholar
  20. S. Park, B. Hong, C.-S. Kim, and H. Ahn, “The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract,” The Journal of Urology, vol. 171, no. 2, part 1, pp. 621–625, 2004. View at Publisher · View at Google Scholar · View at PubMed
  21. M. A. Batata, W. F. Whitmore, Jr., B. S. Hilaris, N. Tokita, and H. Grabstald, “Primary carcinoma of the ureter: a prognostic study,” Cancer, vol. 35, no. 6, pp. 1626–1632, 1975. View at Publisher · View at Google Scholar
  22. H. Akaza, K. Koiso, and T. Niijima, “Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system,” Cancer, vol. 59, no. 7, pp. 1369–1375, 1987. View at Publisher · View at Google Scholar
  23. H. Komatsu, N. Tanabe, S. Kubodera, H. Maezawa, and A. Ueno, “The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract,” The Journal of Urology, vol. 157, no. 5, pp. 1622–1624, 1997. View at Publisher · View at Google Scholar
  24. A. Blanco Díez, M. Ruibal Moldes, G. Suárez Pascual, et al., “Staging of infiltrating bladder cancer. Role of C.T. scan,” Archivos Españoles de Urología, vol. 56, no. 1, pp. 23–29, 2003 (Spanish).
  25. G. J. Jager, J. O. Barentsz, G. O. Oosterhof, J. A. Witjes, and S. J. H. Ruijs, “Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional T1-weighted magnetization-prepared-rapid gradient-echo sequence,” American Journal of Roentgenology, vol. 167, no. 6, pp. 1503–1507, 1996.
  26. S. Jana and M. D. Blaufox, “Nuclear medicine studies of the prostate, testes, and bladder,” Seminars in Nuclear Medicine, vol. 36, no. 1, pp. 51–72, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. O. N. Gofrit, E. Mishani, M. Orevi, et al., “Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma,” The Journal of Urology, vol. 176, no. 3, pp. 940–944, 2006. View at Publisher · View at Google Scholar · View at PubMed
  28. T. Kondo, H. Nakazawa, F. Ito, Y. Hashimoto, H. Toma, and K. Tanabe, “Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract,” The Journal of Urology, vol. 178, no. 4, pp. 1212–1217, 2007. View at Publisher · View at Google Scholar · View at PubMed
  29. J. D. Raman and D. S. Scherr, “Management of patients with upper urinary tract transitional cell carcinoma,” Nature Clinical Practice Urology, vol. 4, no. 8, pp. 432–443, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. O. N. Gofrit, K. C. Zorn, G. D. Steinberg, G. P. Zagaja, and A. L. Shalhav, “The will rogers phenomenon in urological oncology,” The Journal of Urology, vol. 179, no. 1, pp. 28–33, 2008. View at Publisher · View at Google Scholar · View at PubMed
  31. B. H. Bochner, G. Dalbagni, M. W. Kattan, et al., “Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer,” Journal of Clinical Oncology, vol. 24, no. 24, pp. 3967–3972, 2006. View at Publisher · View at Google Scholar · View at PubMed
  32. N. B. Dhar, E. A. Klein, A. M. Reuther, G. N. Thalmann, S. Madersbacher, and U. E. Studer, “Outcome after radical cystectomy with limited or extended pelvic lymph node dissection,” The Journal of Urology, vol. 179, no. 3, pp. 873–878, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. J. P. Stein, J. Cai, S. Groshen, and D. G. Skinner, “Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density,” The Journal of Urology, vol. 170, no. 1, pp. 35–41, 2003. View at Publisher · View at Google Scholar · View at PubMed
  34. P. Bader, F. C. Burkhard, R. Markwalder, and U. E. Studer, “Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?,” The Journal of Urology, vol. 169, no. 3, pp. 849–854, 2003. View at Publisher · View at Google Scholar · View at PubMed
  35. S. E. Eggener, B. S. Carver, D. S. Sharp, R. J. Motzer, G. J. Bosl, and J. Sheinfeld, “Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer,” The Journal of Urology, vol. 177, no. 3, pp. 937–943, 2007. View at Publisher · View at Google Scholar · View at PubMed
  36. S. C. Cozad, S. R. Smalley, M. Austenfeld, M. Noble, S. Jennings, and R. Raymond, “Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure,” Urology, vol. 46, no. 6, pp. 796–800, 1995. View at Publisher · View at Google Scholar
  37. J. E. Busby, G. A. Brown, and S. F. Matin, “Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic,” Urology, vol. 71, no. 3, pp. 413–416, 2008. View at Publisher · View at Google Scholar · View at PubMed
  38. R. Flanigan, Campbell-Walsh Urology, Saunders, Philadelphia, Pa, USA, 9th edition, 2007.
  39. J. P. Donohue and R. S. Foster, “Retroperitoneal lymphadenectomy in staging and treatment: the development of nerve-sparing techniques,” Urologic Clinics of North America, vol. 25, no. 3, pp. 461–468, 1998. View at Publisher · View at Google Scholar
  40. H. B. Grossman, R. B. Natale, C. M. Tangen, et al., “Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer,” The New England Journal of Medicine, vol. 349, no. 9, pp. 859–866, 2003. View at Publisher · View at Google Scholar · View at PubMed
  41. H. von der Maase, L. Sengelov, J. T. Roberts, et al., “Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer,” Journal of Clinical Oncology, vol. 23, no. 21, pp. 4602–4608, 2005. View at Publisher · View at Google Scholar · View at PubMed